Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hospice × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Breast Neoplasms 857 Neoplasms 659 Carcinoma, Non-Small-Cell Lung 643 Prostatic Neoplasms 528 Colorectal Neoplasms 426 Lung Neoplasms 382 Neoplasm Metastasis 330 Multiple Myeloma 310 Leukemia, Myeloid, Acute 304 Ovarian Neoplasms 284 Melanoma 256 Squamous Cell Carcinoma of Head and Neck 235 Pancreatic Neoplasms 224 Recurrence 210 Brain Neoplasms 188 Glioblastoma 184 Stomach Neoplasms 178 Triple Negative Breast Neoplasms 177 Carcinoma, Hepatocellular 176 Uterine Cervical Neoplasms 171 Endometrial Neoplasms 170 Lymphoma 165 Precursor Cell Lymphoblastic Leukemia-Lymphoma 160 Head and Neck Neoplasms 160 Carcinoma, Renal Cell 157 Urinary Bladder Neoplasms 148 Leukemia, Lymphocytic, Chronic, B-Cell 140 Lymphoma, Non-Hodgkin 136 Glioma 134 Lymphoma, Large B-Cell, Diffuse 133

Interventions

Psychotherapy 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡